Last reviewed · How we verify

NCT05012137: SASIS-FICB

The MEV of 0.5% Ropivacaine in Ultrasound-guided SASIS-FICB

Status unknown NA Last updated 27 August 2021
What this trial tests

NA trial testing Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB) with 0.5% ropivacaine in Nerve Block in 54 participants. Status unknown.

Timeline
25 August 2021
Primary endpoint
25 October 2021
25 November 2021

Quick facts

Lead sponsorPeking Union Medical College Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment54
Start date25 August 2021
Primary completion25 October 2021
Estimated completion25 November 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking Union Medical College Hospital

Who can join

18 and older, any sex, with Nerve Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Aim of This Study is to Determine the Minimum Effective Volume of Local Anesthetic (Ropivacaine 0.5%) Required to Produce an Effective Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block(SASIS-FICB) for Surgical Anesthesia in 90% of Patients Scheduled for Elective Surgery of One Lower Limbs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Nerve Block

Currently open trials in the same condition.

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05012137.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing